Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

162.12 -15.06 (-8.50%)

Streaming Delayed Price Updated: 12:51 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Thursday's session: gap up and gap down stock in the S&P500 index ↗

Today 10:35 EST

Via Chartmill

The Clinical Crisis: A Deep-Dive Into ICON plc (ICLR) Amidst a Transformational Storm

Today 9:51 EST

Date: February 12, 2026 Introduction ICON plc (NASDAQ: ICLR) currently finds itself at a pivotal and precarious crossroads. As the world’s second-largest Clinical Research Organization (CRO), the...

Via Finterra

Get insights into the top movers in the S&P500 index of Thursday's pre-market session. ↗

Today 8:35 EST

Via Chartmill

IQVIA Holdings Inc (NYSE:IQV) Beats Q4 Revenue Estimates and Issues 2026 Guidance ↗

February 05, 2026

Via Chartmill

The Top 5 Analyst Questions From IQVIA’s Q4 Earnings Call

Today 0:36 EST

IQVIA’s fourth quarter was marked by solid top-line growth, surpassing Wall Street’s revenue expectations. However, the market reacted negatively, focusing on margin compression and concerns about the...

Via StockStory

Topics Artificial Intelligence Earnings

IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions

February 10, 2026

From IQVIA

Via Business Wire

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

February 06, 2026

Via Chartmill

IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis

February 06, 2026

Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue...

Via StockStory

Topics Artificial Intelligence

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗

February 05, 2026

Via Chartmill

IQVIA (IQV) Q4 2025 Earnings Call Transcript ↗

February 05, 2026

IQVIA (IQV) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

IQVIA (IQV) Stock Trades Down, Here Is Why

February 05, 2026

Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations.

Via StockStory

What's going on in today's session: S&P500 gap up and gap down stocks ↗

February 05, 2026

Via Chartmill

IQVIA’s (NYSE:IQV) Q4 CY2025 Sales Top Estimates

February 05, 2026

Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue...

Via StockStory

IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

February 05, 2026

From IQVIA Holdings Inc.

Via Business Wire

IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings

February 03, 2026

Clinical research company IQVIA (NYSE: IQV) will be reporting results this Thursday before market hours. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration

January 29, 2026

From IQVIA

Via Business Wire

FDA Codifies AI’s Role in Drug Production: New 2026 Guidelines Set Global Standard for Pharma Safety and Efficiency

January 28, 2026

In a landmark shift for the biotechnology and pharmaceutical industries, the U.S. Food and Drug Administration (FDA) has officially entered what experts call the “Enforcement Era” of artificial...

Via TokenRing AI

Topics Artificial Intelligence Economy

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors ↗

January 25, 2026

Via MarketBeat

IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year

January 22, 2026

From IQVIA

Via Business Wire

IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

January 20, 2026

From IQVIA

Via Business Wire

2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down

January 12, 2026

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an...

Via StockStory

Topics Credit Cards

3 Inflated Stocks with Open Questions

January 11, 2026

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

Via StockStory

3 Reasons to Sell IQV and 1 Stock to Buy Instead

January 11, 2026

What a time it’s been for IQVIA. In the past six months alone, the company’s stock price has increased by a massive 51.4%, reaching $242.50 per share. This performance may have investors wondering how...

Via StockStory

1 S&P 500 Stock to Consider Right Now and 2 We Turn Down

January 07, 2026

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

1 Profitable Stock to Target This Week and 2 Facing Challenges

January 06, 2026

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Backbone of Discovery: A Deep Dive into Charles River Laboratories (CRL)

December 23, 2025

In the complex ecosystem of modern medicine, few companies carry as much institutional weight—or stir as much controversy—as Charles River Laboratories International, Inc. (NYSE: CRL). As of December...

Via PredictStreet

Topics Animal Testing Artificial Intelligence Economy

Navigating the Labyrinth: Why Trust, Training, and Data are Paramount for Healthcare AI’s Future

December 12, 2025

Artificial Intelligence (AI) stands at the precipice of revolutionizing healthcare, promising breakthroughs in diagnostics, personalized treatment, and operational efficiency. However, the path to...

Via TokenRing AI

Topics Artificial Intelligence

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗

December 04, 2025

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

Gapping S&P500 stocks in Thursday's session ↗

December 04, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform

December 02, 2025

From IQVIA

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.